Myriad Genetics (MYGN) Current Taxes (2014 - 2020)

Myriad Genetics (MYGN) has reported Current Taxes for 7 consecutive years, with $6.1 million the latest figure, recorded in Q2 2020.

• In Q2 2020, Current Taxes rose 103.33% year-over-year to $6.1 million; the TTM figure through Jun 2020 stood at $6.1 million (up 103.33% YoY), while the FY2020 annual figure was $6.1 million, up 103.33% from the prior year.
• Current Taxes improved to $6.1 million in Q2 2020 per MYGN's latest filing, from $3.5 million in the prior quarter.
• Across five years, Current Taxes topped out at $9.8 million in Q3 2018 and bottomed at $2.3 million in Q1 2016.
• Historically, Current Taxes has averaged $4.6 million across 5 years, with a median of $3.6 million in 2019.
• Annual changes were most pronounced in 2017 — Current Taxes surged 168.75% — and 2018, when it plunged 39.44%.
• Myriad Genetics' Current Taxes stood at $3.0 million in 2016, then advanced by 6.67% to $3.2 million in 2017, then jumped by 53.12% to $4.9 million in 2018, then fell by 18.37% to $4.0 million in 2019, then soared by 52.5% to $6.1 million in 2020.
• Business Quant data shows MYGN's Current Taxes at $6.1 million in Q2 2020, $3.5 million in Q1 2020, and $4.0 million in Q4 2019.